US EQUITY OPEN: Indices mixed as long-end yields fall following US Treasury buyback announcement
US markets opened mixed as Treasury buybacks eased yields. Merck and Moderna surged on successful cancer vaccine trials, while corporate earnings showed divergent trends between tech and retail sectors.
News detail
US EQUITY OPEN: Stocks have opened mixed, with the SPX up around 0.4% while the NDX is -0.3%. Underlying strength is more encouraging, with the equal-weight S&P 500 ETF firmer by over 1.3%. Sectors are predominantly higher, with notable outperformance in Health Care, led by gains in Merck (MRK) and Moderna (MRNA) after their Phase 3 trial showed their vaccine succeeded in preventing cancer from returning or spreading in high-risk melanoma patients. Technology, Communication Services and Industrials lag, limiting gains in the headline indices despite the positive breadth. Broader sentiment is being supported by the US Treasury announcing it will increase the amount of long-end securities it buys back, following the large amount of offers submitted at recent buyback operations. The move should provide additional support for liquidity at the long end following the pronounced recent steepening of the Treasury curve and has helped ease some of the pressure from elevated yields on the broader equity space. The Treasury announcement supported T-notes, particularly at the long end, resulting in a flatter yield curve. Lower yields are weighing on the Dollar and supporting G10 currencies, particularly the CHF and Yen, while the Kiwi also outperforms and gains against the Aussie. Oil prices are marginally firmer amid further incidents reported in Al Mukha, Yemen. Meanwhile, Iran said a new passage through the Strait of Hormuz will be announced with Oman. Attention ahead turns to the FOMC Minutes. STOCK SPECIFICS Merck & Co. (MRK) / Moderna (MRNA): Companies' vaccine succeeds in preventing melanoma from returning Analog Devices (ADI): EPS and revenue topped Wall Street expectations, as did next-quarter outlook Toll Brothers (TOL): Top and bottom line beat Lowe's Companies (LOW): Revenue and comparable sales light, as was top-line FY guidance Estée Lauder Companies (EL): Strong results, with quarterly metrics beating expectations and FY outlook lifted Nebius Group (NBIS): To offer USD 4.5bln of convertible senior notes Samsung Electronics: Reportedly raises prices for advanced contract chipmaking services by 10-15% for new orders SK Hynix: To buy back KRW 40tln in treasury shares
Related stocks
9 stocksWhat do investors think?
StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
